Is discontinuation of clopidogrel necessary for intracapsular hip fracture surgery? Analysis of 102 hemiarthroplasties

Journal of Orthopaedics and Traumatology

Volumn 14, Issue 3, 2013, Pages 171-177

  Hossain, Fahad S ^a,b   Rambani, Rohit ^c   Ribee, Helen ^d   Koch, Lutz ^d  

^a Northern Lincolnshire and Goole Hospitals NHS Foundation Trust   (United Kingdom)

^b Leeds Teaching Hospitals NHS Trust ^*  (United Kingdom)

^c LEEDS TEACHING HOSPITALS NHS TRUST   (United Kingdom)

^d MID YORKSHIRE HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Clopidogrel; Complications; Hip fracture; Transfusion

Indexed keywords

CLOPIDOGREL; HEMOGLOBIN;

ADULT; AGE; AGED; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; COMORBIDITY; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE CLASSIFICATION; FEMALE; GENDER; HEMATOMA; HEMOGLOBIN BLOOD LEVEL; HIP FRACTURE; HIP HEMIARTHROPLASTY; HUMAN; HYPERTENSION; INTRACAPSULAR HIP FRACTURE; KIDNEY DISEASE; LENGTH OF STAY; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; OPERATION DURATION; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PREOPERATIVE CARE; PRIORITY JOURNAL; REGRESSION ANALYSIS; REOPERATION; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; THROMBOEMBOLISM; THYROID DISEASE; WOUND INFECTION;

AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; COMORBIDITY; DATABASES, FACTUAL; FEMALE; HEMIARTHROPLASTY; HEMORRHAGE; HIP FRACTURES; HUMANS; MALE; PLATELET AGGREGATION INHIBITORS; POSTOPERATIVE COMPLICATIONS; RETROSPECTIVE STUDIES; RISK FACTORS; TICLOPIDINE; TREATMENT OUTCOME;

EID: 84892950560     PISSN: 15909921     EISSN: 15909999     Source Type: Journal    
DOI: 10.1007/s10195-013-0235-1     Document Type: Article

References (41)

1. Abrahamsen B, van Staa T, Ariely R, Olson M, Cooper C (2009) Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int 20 (10):1633-1650. doi:10.1007/ s00198-009-0920-3
2. Panula J, Pihlajamaki H, Mattila VM, Jaatinen P, Vahlberg T, Aarnio P, Kivela SL Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord 12:105. doi:10.1186/1471-2474-12-105
3. Currie C, Partridge M, PLant F, Roberts J, Wakeman R, Williams A (2011) The National Hip Fracture Database National Report 2011. NHFD
4. Sennerby U, Melhus H, Gedeborg R, Byberg L, Garmo H, Ahlbom A, Pedersen NL, Michaelsson K (2009) Cardiovascular diseases and risk of hip fracture. JAMA 302 (15):1666-1673. doi: 10.1001/jama.2009.1463
5. Sennerby U, Farahmand B, Ahlbom A, Ljunghall S, Michaelsson K (2007) Cardiovascular diseases and future risk of hip fracture in women. Osteoporos Int 18 (10):1355-1362. doi:10.1007/s00198- 007-0386-0
6. Weber AA, Braun M, Hohlfeld T, Schwippert B, Tschope D, Schror K (2001) Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. Br J Clin Pharmacol 52 (3):333-336
7. Jarvis B, Simpson K (2000) Clopidogrel: a review of its use in the prevention of atherothrombosis. Drugs 60 (2):347-377
8. Squizzato A, Keller T, Romualdi E, Middeldorp S Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular disease. Cochrane Database Syst Rev (1):CD005158. doi:10.1002/ 14651858.CD005158.pub3
9. Mehta SR, Yusuf S, Peters RJ, Bertrand ME, Lewis BS, Natarajan MK, Malmberg K, Rupprecht H, Zhao F, Chrolavicius S, Copland I, Fox KA (2001) Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358 (9281):527-533
10. Blasco-Colmenares E, Perl TM, Guallar E, Baumgartner WA, Conte JV, Alejo D, Pastor-Barriuso R, Sharrett AR, Faraday N (2009) Aspirin plus clopidogrel and risk of infection after coronary artery bypass surgery. Arch Intern Med 169 (8):788-796. doi:10.1001/archinternmed.2009.42
11. Pickard AS, Becker RC, Schumock GT, Frye CB (2008) Clopidogrel- associated bleeding and related complications in patients undergoing coronary artery bypass grafting. Pharmacotherapy 28 (3):376-392. doi:10.1592/phco.28.3. 376
12. Horlocker TT, Wedel DJ, Benzon H, Brown DL, Enneking FK, Heit JA, Mulroy MF, Rosenquist RW, Rowlingson J, Tryba M, Yuan CS (2003) Regional anesthesia in the anticoagulated patient: defining the risks (the second ASRA Consensus Conference on Neuraxial Anesthesia and Anticoagulation). Reg Anesth Pain Med 28 (3):172-197. doi:10.1053/rapm.2003.50046
13. Palan J, Odutola A, White SP (2007) Is clopidogrel stopped prior to hip fracture surgery - A survey of current practice in the United Kingdom. Injury 38 (11):1279-1285. doi:10.1016/j.injury. 2007.05.014
14. Inman DS, Michla Y, Partington PF (2007) Perioperative management of trauma patients admitted on clopidogrel (Plavix). A survey of orthopaedic departments across the United Kingdom. Injury 38 (5):625-630. doi:10.1016/j.injury.2007.01.011
15. Sambu N, Warner T, Curzen N Clopidogrel withdrawal: is there a ''rebound'' phenomenon? Thromb Haemost 105 (2):211-220. doi:10.1160/TH10-08-0554
16. Benzon HT, McCarthy RJ, Benzon HA, Kendall MC, Robak S, Lindholm PF, Kallas PG, Katz JA Determination of residual antiplatelet activity of clopidogrel before neuraxial injections. Br J Anaesth 107 (6):966-971. doi:10.1093/bja/aer298
17. Lefaivre KA, Macadam SA, Davidson DJ, Gandhi R, Chan H, Broekhuyse HM (2009) Length of stay, mortality, morbidity and delay to surgery in hip fractures. J Bone Joint Surg Br 91 (7):922- 927. doi:10.1302/0301-620X.91B7. 22446
18. Shiga T, Wajima Z, Ohe Y (2008) Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression. Can J Anaesth 55 (3): 146-154. doi:10.1007/BF03016088
19. Ho PM, Peterson ED, Wang L, Magid DJ, Fihn SD, Larsen GC, Jesse RA, Rumsfeld JS (2008) Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome. JAMA 299 (5):532-539. doi:10.1001/ jama.299.5.532
20. Bursac Z, Gauss CH, Williams DK, Hosmer DW (2008) Purposeful selection of variables in logistic regression. Source Code Biol Med 3:17. doi:10.1186/1751-0473-3-17
21. Lumley T, Kronmal R, Ma S (2006) Relative risk regression in medical research: models, contrasts, estimators, and algorithms. UW Biostatistics Working Paper Series (Working Paper 293)
22. McNutt LA, Wu C, Xue X, Hafner JP (2003) Estimating the r elative risk in cohort studies and clinical trials of common outcomes. Am J Epidemiol 157 (10):940-943
23. Rhodes DA, Severson EP, Hodrick JT, Dunn HK, Hofmann AA Discontinuation of warfarin is unnecessary in total knee arthroplasty. Clin Orthop Relat Res 468 (1):120-126. doi:10.1007/ s11999-009-1128-8
24. Steinhubl SR, Berger PB, Mann JT 3rd, Fry ET, DeLago A, Wilmer C, Topol EJ (2002) Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 288 (19):2411-2420
25. Vicenzi MN, Meislitzer T, Heitzinger B, Halaj M, Fleisher LA, Metzler H (2006) Coronary artery stenting and non-cardiac surgery - a prospective outcome study. Br J Anaesth 96 (6):686-693. doi:10.1093/bja/ael083
26. Parker MJ, Gurusamy KS, Azegami S (2010) Arthroplasties (with and without bone cement) for proximal femoral fractures in adults. Cochrane Database Syst Rev (6):CD001706. doi:10.1002/ 14651858.CD001706.pub4
27. Hansen SK, Brix M, Birkelund L, Troelsen A (2010) Can introduction of an uncemented, hydroxyapatite coated hemiarthroplasty for displaced femoral neck fractures be recommended? Hip Int 20 (1):109-114
28. Figved W, Opland V, Frihagen F, Jervidalo T, Madsen JE, Nordsletten L (2009) Cemented versus uncemented hemiarthroplasty for displaced femoral neck fractures. Clin Orthop Relat Res 467 (9):2426-2435. doi:10.1007/s11999-008-0672- y
29. Nwachuku IC, Jones M, Clough TM (2011) Clopidogrel: is a surgical delay necessary in fractured neck of femur? Ann R Coll Surg Engl 93 (4):310-313. doi:10.1308/003588411X571106
30. Kennedy MT, Roche S, Fleming SM, Lenehan B, Curtin W (2006) The association between aspirin and blood loss in hip fracture patients. Acta Orthop Belg 72 (1):29-33
31. Nydick JA, Farrell ED, Marcantonio AJ, Hume EL, Marburger R, Ostrum RF The use of clopidogrel (Plavix) in patients undergoing nonelective orthopaedic surgery. J Orthop Trauma 24 (6):383-386. doi:10.1097/BOT.0b013e3181c3f3d9
32. Collinge CA, Weaver T, Talabock C, Schuster R (2008) Effects of Clopidogrel (Plavix-) on bleeding and complications in patients having hip fracture surgery. In: Orthopaedic Trauma Association Annual Meeting, Denver. OTA
33. ChechikO, Thein R, FichmanG, HaimA, TovTB, SteinbergELThe effect of clopidogrel and aspirin on blood loss in hip fracture surgery. Injury 42 (11):1277-1282. doi:10.1016/j.injury.2011.01.011
34. Edwards C, Counsell A, Boulton C, Moran CG (2008) Early infection after hip fracture surgery: risk factors, costs and outcome. J Bone Joint Surg Br 90 (6):770-777. doi:10.1302/0301- 620X.90B6.20194
35. Partanen J, Syrjala H, Vahanikkila H, Jalovaara P (2006) Impact of deep infection after hip fracture surgery on function and mortality. J Hosp Infect 62 (1):44-49. doi:10.1016/j.jhin.2005. 04.020
36. Thyagarajan D, Sunderamoorthy D, Haridas S, Beck S, Praveen P, Johansen A Surgical site infection following hip fracture surgery - the role of wound surveillance. J Infect Prev 12 (1):44-47. doi:10.1177/1757177410375488
37. Sanchez-Ballester J, Smith M, Hassan K, Kershaw S, Elsworth CS, Jacobs L (2005) Wound infection in the management of hip fractures: a comparison between low-molecular weight heparin and mechanical prophylaxis. Acta Orthop Belg 71 (1):55-59
38. Parker MJ, Handoll HH, Griffiths R (2004) Anaesthesia for hip fracture surgery in adults. Cochrane Database Syst Rev (4):CD000521. doi:10.1002/ 14651858.CD000521.pub2
39. Heidari SM, Soltani H, Hashemi SJ, Talakoub R, Soleimani B (2011) Comparative study of two anesthesia methods according to postoperative complications and one month mortality rate in the candidates of hip surgery. J Res Med Sci 16 (3):323-330
40. Moja L, Piatti A, Pecoraro V, Ricci C, Virgili G, Salanti G, Germagnoli L, Liberati A, Banfi G (2012) Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. Ameta-analysis andmeta-regression of over 190, 000 patients. PLoS ONE 7 (10):e46175. doi:10.1371/journal.pone. 0046175
41. Chassot PG, Delabays A, Spahn DR (2007) Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 99 (3):316-328. doi:10.1093/bja/aem209